UK Markets close in 3 hrs 27 mins

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.730.00 (0.00%)
At close: 4:00PM EDT
6.42 -1.31 (-16.95%)
Pre-market: 08:03AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.73
Bid6.25 x 1800
Ask7.99 x 1800
Day's range7.41 - 7.99
52-week range6.51 - 23.85
Avg. volume804,653
Market cap481.799M
Beta (5Y monthly)1.10
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Here's Why Omeros Stock Is Tanking Today

    Shares of Omeros (NASDAQ: OMER), a biopharmaceutical company, are falling today after the company made a disclosure regarding narsoplimab, an experimental treatment to address side effects of stem cell transplants. Omeros has just one revenue stream at the moment, Omidria, an expensive eye-drop solution that gets added to the bill when Medicare patients go under the knife for lens replacements and cataract removals.

  • Zacks

    Do Options Traders Know Something About Omeros (OMER) Stock We Don't?

    Investors need to pay close attention to Omeros (OMER) stock based on the movements in the options market lately.

  • Motley Fool

    Why Omeros Stock Is Plummeting This Week

    Shares of Omeros Corporation (NASDAQ: OMER) are down 12.2% since Monday. Omeros didn't have any big news that would have affected its stock price this month. Its last real news was its second-quarter earnings report that came out on Aug. 9, which showed the biotech company reporting $28.8 million of revenue, up 37% year over year, and a net income loss of $28.6 million, compared to a loss of $35.1 million in the same period in 2020.